Drug recall
Apheresis PF24 Plasma
FDA recall event 84805 · Class II, Class III · South Texas Blood & Tissue Center
Key facts
| Event ID | 84805 |
|---|---|
| Recall numbers | B-0272-2020, B-0273-2020, B-0274-2020, B-0275-2020, B-0276-2020, B-0277-2020, B-0278-2020, B-0279-2020 |
| Recalling firm | South Texas Blood & Tissue Center |
| Product type | Biologics |
| Products | Apheresis PF24 Plasma, Apheresis Pooled Cryoprecipitated AHF, Blood and Blood Products for Reprocessing, Fresh Frozen Plasma, Platelets and 3 more |
| Classification | Class II, Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. |
| Initiation date | Dec 18, 2019 |
| Report date | Feb 12, 2020 |
| Termination date | Feb 5, 2020 |
| City | San Antonio |
| State | TX |
| Country | United States |
| FEI number | 1676815 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: